Literature DB >> 11480916

Skewed X inactivation in X-linked disorders.

I B Van den Veyver1.   

Abstract

X chromosome inactivation is a process by which the dosage of proteins transcribed from genes on the X chromosome is equalized between males (XY) and females (XX) through the silencing of most genes on one of the two X chromosomes in females. Although the choice of which of the two X's is inactivated is entirely random, not all women have a 50:50 ratio of cells with one or the other X chromosomes active. A number of different mechanisms lead to extremely skewed ratios and this can result in expression of the phenotype of X-linked recessive disorders in females. Nonrandom X inactivation patterns are also associated with selective female survival in male-lethal X-linked dominant disorders or with variable severity of the phenotype in women carrying X-linked dominant mutations. These features are important for the study and gene identification of X-linked disorders and for counseling of affected families.

Entities:  

Mesh:

Year:  2001        PMID: 11480916     DOI: 10.1055/s-2001-15398

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  31 in total

1.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

Review 2.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

3.  A novel ribosomopathy caused by dysfunction of RPL10 disrupts neurodevelopment and causes X-linked microcephaly in humans.

Authors:  Susan S Brooks; Alissa L Wall; Christelle Golzio; David W Reid; Amalia Kondyles; Jason R Willer; Christina Botti; Christopher V Nicchitta; Nicholas Katsanis; Erica E Davis
Journal:  Genetics       Date:  2014-10       Impact factor: 4.562

4.  X inactivation in a mammal species with three sex chromosomes.

Authors:  Frédéric Veyrunes; Julie Perez
Journal:  Chromosoma       Date:  2017-12-18       Impact factor: 4.316

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  Skewed X inactivation in Lesch-Nyhan disease carrier females.

Authors:  Rosa J Torres; Juan G Puig
Journal:  J Hum Genet       Date:  2017-09-14       Impact factor: 3.172

Review 7.  X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene?

Authors:  Stéphanie Olivier-Van Stichelen; Lara K Abramowitz; John A Hanover
Journal:  Biochem Biophys Res Commun       Date:  2014-06-21       Impact factor: 3.575

8.  Goltz-Gorlin (focal dermal hypoplasia) and the microphthalmia with linear skin defects (MLS) syndrome: no evidence of genetic overlap.

Authors:  May-Britt Harmsen; Silvia Azzarello-Burri; M Mar García González; Gabriele Gillessen-Kaesbach; Peter Meinecke; Dietmar Müller; Anita Rauch; Eva Rossier; Eva Seemanova; Christiane Spaich; Bernhard Steiner; Dagmar Wieczorek; Martin Zenker; Kerstin Kutsche
Journal:  Eur J Hum Genet       Date:  2009-03-11       Impact factor: 4.246

Review 9.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

10.  A genome-wide screen for copy number alterations in Aicardi syndrome.

Authors:  Xiaoling Wang; V Reid Sutton; Tanya N Eble; Richard Alan Lewis; Preethi Gunaratne; Ankita Patel; Ignatia B Van den Veyver
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.